Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Gross Profit | 20,220 | N/A | 3,150 | 2,590 |
| Operating Expenses | 7,200 | 0 | 6,510 | 5,940 |
| Operating Income | -7,200 | N/A | -6,510 | -5,940 |
| Pre-tax Income | -7,200 | 0 | -6,510 | -5,940 |
| Net Income Continuous | -7,200 | N/A | -6,510 | -5,940 |
| Net Income | $-7,200 | $N/A | $-6,510 | $-5,940 |
| EBITDA(a) | $-6,770 | $N/A | $-6,090 | $-5,940 |